Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-DOTATOC PET/CT in Malignant Glioma
NCT01460706Phase 3Completed
- Sponsor
- Turku University Hospital
- Start
- Oct 2011
- Primary completion
- Dec 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of gallium Ga 68-edotreotide in glioma, sponsored by Turku University Hospital. Started Oct 2011; status: completed.
02
Drugs
gallium Ga 68-edotreotide
03
Conditions
glioma
Beyond the preview
Go deeper on NCT01460706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01460706.